Details for 2022754752
Up to date per 01.04.2026
Actions
Details for 2022754752
Granted/Registered
European Patent
26.07.2023 A
09.10.2024 B1
27.07.2021
US
202163226118 P
C07K 16/28 20060101AFI20230203BHEP
Owner
AbbVie Inc.1 N. Waukegan Road North Chicago, IL 60064US
Representative
Authorized Recipients
Paul CosmoviciGumpendorfer Straße 1421060 WienAT
Inventor
MCCLUSKEY, Andrew, J. Chicago, IL 60064US
SCHMIDT PAUSTIAN, Amanda, M. Chicago, IL 60064US
SEAGAL, Jane Chicago, IL 60064US
WILSBACHER, Julie, L. Chicago, IL 60064US
Information about Fees